GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » HTG Molecular Diagnostics Inc (STU:65H) » Definitions » Cyclically Adjusted PB Ratio

HTG Molecular Diagnostics (STU:65H) Cyclically Adjusted PB Ratio : (As of Jun. 08, 2024)


View and export this data going back to 2017. Start your Free Trial

What is HTG Molecular Diagnostics Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


HTG Molecular Diagnostics Cyclically Adjusted PB Ratio Historical Data

The historical data trend for HTG Molecular Diagnostics's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HTG Molecular Diagnostics Cyclically Adjusted PB Ratio Chart

HTG Molecular Diagnostics Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

HTG Molecular Diagnostics Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of HTG Molecular Diagnostics's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, HTG Molecular Diagnostics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HTG Molecular Diagnostics's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, HTG Molecular Diagnostics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where HTG Molecular Diagnostics's Cyclically Adjusted PB Ratio falls into.



HTG Molecular Diagnostics Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

HTG Molecular Diagnostics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2023 is calculated as:

For example, HTG Molecular Diagnostics's adjusted Book Value per Share data for the three months ended in Mar. 2023 was:

Adj_Book=Book Value per Share/CPI of Mar. 2023 (Change)*Current CPI (Mar. 2023)
=0.201/127.3478*127.3478
=0.201

Current CPI (Mar. 2023) = 127.3478.

HTG Molecular Diagnostics Quarterly Data

Book Value per Share CPI Adj_Book
201212 -16,821.500 96.871 -22,113.727
201309 0.000 98.790 0.000
201312 -21,261.500 98.326 -27,537.050
201403 0.000 99.695 0.000
201406 0.000 100.560 0.000
201409 -27,372.000 100.428 -34,709.154
201412 -1,510.345 99.070 -1,941.452
201503 -1,842.235 99.621 -2,354.969
201506 645.689 100.684 816.685
201509 526.079 100.392 667.337
201512 407.891 99.792 520.521
201603 243.731 100.470 308.933
201606 91.294 101.688 114.331
201609 -50.331 101.861 -62.924
201612 -120.227 101.863 -150.307
201703 -228.874 102.862 -283.356
201706 -21.838 103.349 -26.909
201709 -54.548 104.136 -66.707
201712 -33.415 104.011 -40.912
201803 159.416 105.290 192.814
201806 147.574 106.317 176.766
201809 123.448 106.507 147.604
201812 116.743 105.998 140.257
201903 89.238 107.251 105.960
201906 64.760 108.070 76.312
201909 79.187 108.329 93.089
201912 66.847 108.420 78.517
202003 57.391 108.902 67.112
202006 44.511 108.767 52.115
202009 34.833 109.815 40.394
202012 27.478 109.897 31.841
202103 27.120 111.754 30.904
202106 24.782 114.631 27.531
202109 20.210 115.734 22.238
202112 14.555 117.630 15.758
202203 14.304 121.301 15.017
202206 5.724 125.017 5.831
202209 1.325 125.227 1.347
202212 2.299 125.222 2.338
202303 0.201 127.348 0.201

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


HTG Molecular Diagnostics  (STU:65H) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


HTG Molecular Diagnostics Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of HTG Molecular Diagnostics's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


HTG Molecular Diagnostics (STU:65H) Business Description

Traded in Other Exchanges
Address
3430 E. Global Loop, Tucson, AZ, USA, 85706
HTG Molecular Diagnostics Inc is a commercial-stage RNA platform-based life sciences company focused on advancing the promise of precision medicine. Its proprietary NGS-adapted chemistry and HTG EdgeSeq platform automates sample processing and can quickly, robustly, and simultaneously profile hundreds or thousands of molecular targets using a relatively small amount of biological samples, in liquid or solid forms. Its products include instruments, consumables, and software that combine to form its HTG EdgeSeq platform. The company's menu of HTG EdgeSeq molecular profiling panels is automated on its HTG EdgeSeq platform, applying genomic sequencing tools to quickly generate gene expression data using its simplified workflow for customers.

HTG Molecular Diagnostics (STU:65H) Headlines

No Headlines